The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice
AbstractThe human cytokine interleukin (IL)-37 has potent anti-inflammatory capacities, and hematopoietic cell-specific transgenic overexpression of IL-37 in mice protects against septic shock and colitis. In the present study we investigated the effect of hematopoietic expression of IL-37 on atherosclerosis development under low-grade inflammatory conditions. Low-density lipoprotein receptor (LDLr)-deficient mice were lethally irradiated and transplanted with bone marrow from IL-37-transgenic or control wild-type mice and fed a Western-type diet (WTD; 1% cholesterol) for eight weeks. Metabolic and inflammatory parameters were monitored and atherosclerosis was assessed in the aortic valve area. Hematopoietic IL-37 expression did not influence body weight, food intake and plasma cholesterol levels during the study. Plasma soluble E-selectin levels were increased with WTD-feeding as compared to chow-feeding, but were not influenced by IL-37 expression. IL-37 expression reduced the inflammatory state as indicated by reduced white blood cell counts and by reduced basal and lipopolysaccharide-induced cytokine response by peritoneal macrophages ex vivo. IL-37 expression did not influence the atherosclerotic lesion area. Lesion composition was marginally affected. Smooth muscle cell content was decreased, but macrophage and collagen content were not different. We conclude that under low-grade inflammatory conditions, hematopoietic IL-37 expression reduces the inflammatory state, but does not influence atherosclerosis development in hyperlipidemic LDLr-deficient mice. View Full-Text
Share & Cite This Article
Hoeke, G.; Khedoe, P.P.S.; Van Diepen, J.A.; Pike-Overzet, K.; Van de Ven, B.; Vazirpanah, N.; Mol, I.; Hiemstra, P.S.; Staal, F.J.; Stienstra, R.; Netea, M.G.; Dinarello, C.A.; Rensen, P.C.; Berbée, J.F. The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice. Int. J. Mol. Sci. 2017, 18, 1672.
Hoeke G, Khedoe PPS, Van Diepen JA, Pike-Overzet K, Van de Ven B, Vazirpanah N, Mol I, Hiemstra PS, Staal FJ, Stienstra R, Netea MG, Dinarello CA, Rensen PC, Berbée JF. The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice. International Journal of Molecular Sciences. 2017; 18(8):1672.Chicago/Turabian Style
Hoeke, Geerte; Khedoe, P. Padmini S.; Van Diepen, Janna A.; Pike-Overzet, Karin; Van de Ven, Britt; Vazirpanah, Nadia; Mol, Isabel; Hiemstra, Pieter S.; Staal, Frank J.; Stienstra, Rinke; Netea, Mihai G.; Dinarello, Charles A.; Rensen, Patrick C.; Berbée, Jimmy F. 2017. "The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice." Int. J. Mol. Sci. 18, no. 8: 1672.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.